Clinical Trial Detail

NCT ID NCT03352427
Title Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring PDGFR/FGFR Alterations
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors University of Michigan Cancer Center
Indications

brain stem glioma

malignant glioma

Therapies

Dasatinib + Everolimus

Everolimus

Age Groups: child adult

Additional content available in CKB BOOST